未登录

V

Vasilios Liapis

University of Adelaide

H指数:19

被引数:846

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Antibody drug conjugates: hitting the mark in pancreatic cancer?

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2023-10-259

OAAI

An anti-mesothelin targeting antibody drug conjugate induces pyroptosis and ignites antitumor immunity in mouse models of cancer

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2023-03-0615

OAAI

Fc gamma receptor is not required for in vivo processing of radio- and drug-conjugates of the dead tumor cell-targeting monoclonal antibody, APOMAB®

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2022-07-011

OAAI

Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models (Jul, 10.1007/s11307-021-01620-1, 2021)

MOLECULAR IMAGING AND BIOLOGY

IF2.5

2021-08-160

OAAI

Positron Emission Tomographic Imaging of Tumor Cell Death Using Zirconium-89-Labeled APOMAB® Following Cisplatin Chemotherapy in Lung and Ovarian Cancer Xenograft Models

MOLECULAR IMAGING AND BIOLOGY

IF2.5

2021-07-068

OAAI

Tumour-associated macrophages process drug and radio-conjugates of the dead tumour cell-targeting APOMAB® antibody

JOURNAL OF CONTROLLED RELEASE

IF11.5

2020-11-018

PREAI

APOMAB Antibody-Drug Conjugates Targeting Dead Tumor Cells are Effective In Vivo

MOLECULAR CANCER THERAPEUTICS

IF5.5

2019-02-0417

OAAI

Adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells in combination with zoledronic acid inhibits cancer growth and limits osteolysis in a murine model of osteolytic breast cancer

体外扩增的vγ9vδ2t细胞与唑来膦酸联合过继转移可抑制溶骨性乳腺癌小鼠模型的癌症生长并限制溶骨性

IF10.1

2017-02-0122

OAAI

Peroxidase enzymes inhibit osteoclast differentiation and bone resorption

过氧化物酶抑制破骨细胞分化和骨吸收

MOLECULAR AND CELLULAR ENDOCRINOLOGY

IF3.6

2017-01-0119

PREAI

Peroxidase Enzymes Regulate Collagen Biosynthesis and Matrix Mineralization by Cultured Human Osteoblasts

过氧化物酶调节培养的人成骨细胞的胶原生物合成和基质矿化

CALCIFIED TISSUE INTERNATIONAL

IF3.2

2015-12-0715

PREAI

Uncovering a new role for peroxidase enzymes as drivers of angiogenesis

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

IF2.8

2015-11-0128

PREAI

Systematic in vitro nanotoxicity study on anodic alumina nanotubes with engineered aspect ratio: Understanding nanotoxicity by a nanomaterial model

IF12.9

2015-04-0137

PREAI

Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma

IF10.1

2015-02-0140

OAAI

Anticancer Efficacy of Apo2L/TRAIL Is Retained in the Presence of High and Biologically Active Concentrations of Osteoprotegerin In Vivo

JOURNAL OF BONE AND MINERAL RESEARCH

IF5.9

2010-09-0321

OAAI

Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2010-02-0132

OAAI

Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2009-10-1243

OAAI

Zoledronic Acid Inhibits Both the Osteolytic and Osteoblastic Components of Osteosarcoma Lesions in a Mouse Model

CLINICAL CANCER RESEARCH

IF10.2

2009-05-1865

OAAI

Apo2L/TRAIL Inhibits Tumor Growth and Bone Destruction in a Murine Model of Multiple Myeloma

CLINICAL CANCER RESEARCH

IF10.2

2009-03-1634

OAAI

The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2006-06-0172

OAAI

Apo2L/tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse

CANCER RESEARCH

IF16.6

2006-05-1628

PREAI